iSERA Lifesciences (BOM:534920) ROCE %: 25.30% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:534920 iSERA Lifesciences Ltd BOM:534920
20 GF Score
Price ₹143.90
! 5 Warning Signs
View Full Analysis

What is iSERA Lifesciences ROCE %?

iSERA Lifesciences BOM:534920 20 ROCE % is 25.30% as of Mar. 2026. GuruFocus rates BOM:534920 with a GF Score™ of 20/100. The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. iSERA Lifesciences's annualized ROCE % for the quarter that ended in Mar. 2026 was 25.30%.

iSERA Lifesciences  (BOM:534920) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

iSERA Lifesciences ROCE % Related Terms

iSERA Lifesciences ROCE % Historical Data

* Premium members only.

The historical data trend for iSERA Lifesciences's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

iSERA Lifesciences ROCE % Chart

iSERA Lifesciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -10.86 -5,081.82 0.00 18.84 5.89

iSERA Lifesciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 60.49 -4.09 1.85 -74.72 25.30
BOM:534920
20GF Score
iSERA Lifesciences Ltd BOM:534920
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

iSERA Lifesciences ROCE % Calculation

iSERA Lifesciences's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=3.364/( ( (15.538 - 0.462) + (105.621 - 6.523) )/ 2 )
=3.364/( (15.076+99.098)/ 2 )
=3.364/57.087
=5.89 %

iSERA Lifesciences's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=25.072/( ( (0 - 0) + (105.621 - 6.523) )/ 1 )
=25.072/( ( 0 + 99.098 )/ 1 )
=25.072/99.098
=25.30 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 25.30% mean?
iSERA Lifesciences (BOM:534920) has a ROCE % of 25.30% as of Mar. 2026.
Is iSERA Lifesciences' ROCE % too high?
iSERA Lifesciences' current ROCE % is 25.30%. The Software industry median ROCE % is 5.51. iSERA Lifesciences' value of 25.30% is 359.2% above this industry median. Overall, iSERA Lifesciences has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does iSERA Lifesciences' ROCE % compare to IBM and ACN?
iSERA Lifesciences' ROCE % of 25.30% can be compared against companies in the Software industry. The industry median ROCE % is 5.51. iSERA Lifesciences' value of 25.30% is 359.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Software company?
The median ROCE % among Software companies is 5.51, based on 2,725 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. iSERA Lifesciences's current ROCE % of 25.30% is 359.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Software industry, the median ROCE % is 5.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. iSERA Lifesciences's current ROCE % is 25.30%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iSERA Lifesciences stock overvalued right now?
iSERA Lifesciences (BOM:534920) has a current ROCE % of 25.30%. The current ROCE % is 25.30% and 359.2% above the Software industry median of 5.51. iSERA Lifesciences' overall GF Score™ is 20/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For iSERA Lifesciences (BOM:534920), the current ROCE % is 25.30% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

iSERA Lifesciences Business Description

Address A1-1202, 12th Floor, Boulevard Tower, Phase-2, CTS No. 11, Sadhu Vaswani Chowk, Camp, Pune, MH, IND, 411001
iSERA Lifesciences Ltd, formally known as Covidh Technologies Ltd, is a technology services provider. The company provides IT and IT-enabled services. It derives revenue majorly from the sale of IT and IT-enabled services and Hardware.
20GF Score

Get the complete analysis for BOM:534920

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹143.90
Price